Emerging systemic therapies for atopic dermatitis: oral small molecules and targeted topical agents.
Kelsey B NusbaumCatherine M NguyenAlan B FleischerPublished in: The Journal of dermatological treatment (2020)
Targeted therapeutics including oral small molecules and topical agents show promise for the treatment of atopic dermatitis. The use of validated core measures is necessary for future trials in order to adequately compare agents and progress evidence-based medicine.